DK3003411T3 - Nedbrydelig hæmostat-komposition - Google Patents

Nedbrydelig hæmostat-komposition Download PDF

Info

Publication number
DK3003411T3
DK3003411T3 DK14736422.8T DK14736422T DK3003411T3 DK 3003411 T3 DK3003411 T3 DK 3003411T3 DK 14736422 T DK14736422 T DK 14736422T DK 3003411 T3 DK3003411 T3 DK 3003411T3
Authority
DK
Denmark
Prior art keywords
degradable
hemostat composition
hemostat
composition
degradable hemostat
Prior art date
Application number
DK14736422.8T
Other languages
English (en)
Inventor
Andrew Hoggarth
June Gladman
Craig Hardy
Original Assignee
Medtrade Products Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medtrade Products Ltd filed Critical Medtrade Products Ltd
Application granted granted Critical
Publication of DK3003411T3 publication Critical patent/DK3003411T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/722—Chitin, chitosan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
    • A61L15/28—Polysaccharides or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/64—Use of materials characterised by their function or physical properties specially adapted to be resorbable inside the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/001—Use of materials characterised by their function or physical properties
    • A61L24/0042—Materials resorbable by the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
    • A61L24/08—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0024—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid beta-D-Glucans; (beta-1,3)-D-Glucans, e.g. paramylon, coriolan, sclerotan, pachyman, callose, scleroglucan, schizophyllan, laminaran, lentinan or curdlan; (beta-1,6)-D-Glucans, e.g. pustulan; (beta-1,4)-D-Glucans; (beta-1,3)(beta-1,4)-D-Glucans, e.g. lichenan; Derivatives thereof
    • C08B37/0027—2-Acetamido-2-deoxy-beta-glucans; Derivatives thereof
    • C08B37/003—Chitin, i.e. 2-acetamido-2-deoxy-(beta-1,4)-D-glucan or N-acetyl-beta-1,4-D-glucosamine; Chitosan, i.e. deacetylated product of chitin or (beta-1,4)-D-glucosamine; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00—Materials characterised by their function or physical properties
    • A61L2400/04—Materials for stopping bleeding

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Surgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Polymers & Plastics (AREA)
  • Biochemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Dispersion Chemistry (AREA)
  • Composite Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Biological Depolymerization Polymers (AREA)
DK14736422.8T 2013-05-30 2014-05-28 Nedbrydelig hæmostat-komposition DK3003411T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB1309674.8A GB2514592A (en) 2013-05-30 2013-05-30 Degradable haemostat composition
PCT/GB2014/051624 WO2014191738A1 (en) 2013-05-30 2014-05-28 Degradable haemostat composition

Publications (1)

Publication Number Publication Date
DK3003411T3 true DK3003411T3 (da) 2021-09-20

Family

ID=48805490

Family Applications (1)

Application Number Title Priority Date Filing Date
DK14736422.8T DK3003411T3 (da) 2013-05-30 2014-05-28 Nedbrydelig hæmostat-komposition

Country Status (16)

Country Link
US (3) US10933160B2 (da)
EP (1) EP3003411B1 (da)
JP (1) JP6608808B2 (da)
KR (1) KR102324247B1 (da)
CN (2) CN105431176A (da)
AU (1) AU2014272868C1 (da)
BR (1) BR112015029956B1 (da)
CA (1) CA2913658C (da)
DK (1) DK3003411T3 (da)
ES (1) ES2897623T3 (da)
GB (1) GB2514592A (da)
MX (1) MX2015016387A (da)
PL (1) PL3003411T3 (da)
PT (1) PT3003411T (da)
RU (1) RU2682717C2 (da)
WO (1) WO2014191738A1 (da)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3291847A1 (en) * 2015-05-06 2018-03-14 Gyrus ACMI, Inc. (D.B.A. Olympus Surgical Technologies America) Carboxymethyl chitosan sponge formulation
RU2635465C1 (ru) * 2016-08-10 2017-11-13 Александр Евгеньевич Федотов Гемостатический материал, гемостатическое средство и перевязочный материал на его основе
TR201714879A2 (tr) * 2017-10-03 2019-04-22 Montero Gida Sanayi Ve Ticaret Anonim Sirketi Hemostati̇k kompozi̇syonlar
WO2019133931A1 (en) 2017-12-29 2019-07-04 Tricol Biomedical, Inc. Delivery systems for control of bleeding in transurethral prostatectomy
US20210060203A1 (en) * 2017-12-29 2021-03-04 Tricol Biomedical, Inc. Tissue adherent chitosan material that resists dissolution
US20210059868A1 (en) * 2017-12-29 2021-03-04 Tricol Biomedical, Inc. Chitosan dressing for control of bleeding in transurethral prostatectomy
WO2019133898A1 (en) * 2017-12-29 2019-07-04 Tricol Biomedical, Inc. Chitosan dressing for control of gastrointestinal bleeding
WO2019133894A1 (en) 2017-12-29 2019-07-04 Tricol Biomedical, Inc. Delivery systems for control of gastrointestinal bleeding
US10786596B2 (en) * 2018-01-12 2020-09-29 Boston Scientific Scimed, Inc. Powder for achieving hemostasis
CN109432481A (zh) * 2018-12-06 2019-03-08 广州润虹医药科技股份有限公司 一种止血抗菌的聚氨酯敷料及其制备方法
JPWO2021132663A1 (da) 2019-12-26 2021-07-01
CN111714689B (zh) * 2020-07-09 2022-04-22 石家庄亿生堂医用品有限公司 一种壳聚糖止血粉及其制备方法
CN114748676B (zh) * 2022-04-08 2022-11-18 四川大学 一种具有Janus结构的壳聚糖基高效止血剂、其制备方法及应用

Family Cites Families (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4394373A (en) * 1981-04-06 1983-07-19 Malette William Graham Method of achieving hemostasis
JPS624232A (ja) * 1985-07-01 1987-01-10 Unitika Ltd 止血剤
US5064653A (en) * 1988-03-29 1991-11-12 Ferris Mfg. Co. Hydrophilic foam compositions
US5169535A (en) * 1989-09-22 1992-12-08 Kurita Water Industries Ltd. Method of removing endotoxin
JP3569927B2 (ja) 1993-03-15 2004-09-29 栗田工業株式会社 エンドトキシンの除去方法
US5578661A (en) * 1994-03-31 1996-11-26 Nepera, Inc. Gel forming system for use as wound dressings
WO2002102276A2 (en) * 2001-06-14 2002-12-27 Providence Health System-Oregon Wound dressing and method for controlling severe, life-threatening bleeding
CA2471994A1 (en) * 2001-12-31 2003-07-17 Ares Laboratories, Llc Hemostatic compositions and methods for controlling bleeding
US8269058B2 (en) * 2002-06-14 2012-09-18 Hemcon Medical Technologies, Inc. Absorbable tissue dressing assemblies, systems, and methods formed from hydrophilic polymer sponge structures such as chitosan
US7125967B2 (en) 2003-10-08 2006-10-24 Adjuvant Pharmaceuticals, Llc Water-soluble chitosan having low endotoxin concentration and methods for making and using the same
JP2005145873A (ja) * 2003-11-14 2005-06-09 Kyoko Koto ペプチド及びタンパク性薬物放出制御剤の調製方法及びその薬物放出制御剤
US8703176B2 (en) * 2004-02-23 2014-04-22 Loma Linda University Medical Center Hemostatic agent for topical and internal use
AU2005221699A1 (en) * 2004-03-11 2005-09-22 Medtrade Products Limited Compositions of alpha and beta chitosan and methods of preparing them
CN1833732A (zh) 2005-03-17 2006-09-20 李毅彬 一种抗菌医用敷料的制造方法及其用途
MX336736B (es) 2005-06-14 2016-01-29 Genis Hf Composiciones de derivados de quitina parcialmente desacetilados.
EP1906896A4 (en) * 2005-07-13 2009-05-27 Hemcon Inc HEMOSTATIC COMPOSITIONS, ASSEMBLIES, SYSTEMS, AND METHODS RELATING TO THE USE OF CHITOSAN AGENTS AND COMPRISING A POLY-4-HYDROXY BUTYRATE POLYMER MESH MATERIAL
WO2007040557A1 (en) * 2005-09-21 2007-04-12 Surmodics, Inc. Coatings and articles including natural biodegradable polysaccharides
GB0526503D0 (en) * 2005-12-29 2006-02-08 Medtrade Products Ltd Hemostatic material
US20080248508A1 (en) 2006-08-17 2008-10-09 Shenda Baker Methods of making a chitosan product having an ultra-low endotoxin concentration and the ultra-low endotoxin chitosan product derived therefrom and method of accurately determining inflammatory and anti-inflammatory cellular response to such materials
WO2008063503A2 (en) * 2006-11-13 2008-05-29 Hawaii Chitopure, Inc. Methods of making a chitosan product having an ultra-low endotoxin concentration and the ultra-low endotoxin chitosan product derived therefrom and method of accurately determining inflammatory and anti-inflammatory cellular response to such materials.
US8932560B2 (en) * 2007-09-04 2015-01-13 University of Maryland, College Parke Advanced functional biocompatible polymeric matrix used as a hemostatic agent and system for damaged tissues and cells
CN101081308A (zh) * 2007-05-14 2007-12-05 罗晓浔 壳聚糖止血剂
CN101053669B (zh) * 2007-05-22 2010-05-26 中国海洋大学 一种水溶性壳聚糖基止血愈创海绵及其制备方法和应用
WO2009011856A1 (en) * 2007-07-16 2009-01-22 Hemcon Medical Technologies, Inc. Absorbable tissue dressing assemblies, systems, and methods formed from hydrophilic polymer sponge structures such as chistosan
CZ2007716A3 (cs) * 2007-10-15 2009-04-29 Elmarco S. R. O. Zpusob výroby nanovláken
CN101903408B (zh) * 2007-10-30 2013-08-14 粘凝胶股份公司 壳聚糖组合物
GB2461019B (en) * 2008-04-25 2013-06-05 Medtrade Products Ltd Haemostatic material
GB2463523B (en) * 2008-09-17 2013-05-01 Medtrade Products Ltd Wound care device
US20100100123A1 (en) * 2008-10-17 2010-04-22 Confluent Surgical, Inc. Hemostatic implant
US8993540B2 (en) 2009-03-16 2015-03-31 University Of Memphis Research Foundation Compositions and methods for delivering an agent to a wound
CN101601643A (zh) * 2009-06-30 2009-12-16 复旦大学附属中山医院 一种骨骼止血凝胶
US8728498B2 (en) * 2009-07-14 2014-05-20 Trustees Of Tufts College Electrospun silk material systems for wound healing
RU2468129C2 (ru) * 2010-12-30 2012-11-27 Государственное образовательное учреждение высшего профессионального образования "Саратовский государственный университет им. Н.Г. Чернышевского" Биополимерное волокно, состав формовочного раствора для его получения, способ приготовления формовочного раствора, полотно биомедицинского назначения, способ его модификации, биологическая повязка и способ лечения ран
GB201104175D0 (en) 2011-03-11 2011-04-27 Medtrade Products Ltd Haemostatic material
GB201205174D0 (en) * 2012-03-23 2012-05-09 Medtrade Products Ltd Process for producing low endotoxin chitosan
CN103100107B (zh) * 2013-01-25 2014-08-20 安吉县阳光医药用品有限责任公司 一种几丁质医用生物敷料的制备方法

Also Published As

Publication number Publication date
KR102324247B1 (ko) 2021-11-08
WO2014191738A1 (en) 2014-12-04
US10933160B2 (en) 2021-03-02
AU2014272868A1 (en) 2016-01-21
CN114949334A (zh) 2022-08-30
GB201309674D0 (en) 2013-07-17
RU2015155733A (ru) 2017-07-06
PT3003411T (pt) 2021-09-22
AU2014272868C1 (en) 2018-09-06
BR112015029956B1 (pt) 2020-11-03
EP3003411B1 (en) 2021-06-16
BR112015029956A2 (pt) 2017-07-25
EP3003411A1 (en) 2016-04-13
CA2913658C (en) 2022-08-02
PL3003411T4 (pl) 2022-01-24
US20170258958A1 (en) 2017-09-14
RU2682717C2 (ru) 2019-03-21
US20160106882A1 (en) 2016-04-21
CN105431176A (zh) 2016-03-23
CA2913658A1 (en) 2014-12-04
AU2014272868B2 (en) 2018-03-08
KR20160033661A (ko) 2016-03-28
ES2897623T3 (es) 2022-03-02
WO2014191738A8 (en) 2015-12-23
JP6608808B2 (ja) 2019-11-20
JP2016522208A (ja) 2016-07-28
PL3003411T3 (pl) 2022-01-24
US20170258959A1 (en) 2017-09-14
MX2015016387A (es) 2016-10-14
GB2514592A (en) 2014-12-03

Similar Documents

Publication Publication Date Title
DK2984138T3 (da) Polymersammensætning
DK3030262T3 (da) Kombineret farmaceutisk sammensætning
DK2988791T3 (da) Tværbundet silke-hyaluronsyresammensætning
DK3003411T3 (da) Nedbrydelig hæmostat-komposition
DK2970729T3 (da) Klæbemiddelsammensætning
DK2943549T3 (da) Synergistisk h2s-scavenger-sammensætning
BR112016010669A2 (pt) composição desinfetante
FR2997014B1 (fr) Composition sterile dermo-injectable
BR112014032798A2 (pt) composição
DE202014011212U8 (de) Superabsorberpolymerzusammensetzung
DK3027750T3 (da) Biokatalytisk sammensætning
DK3003412T3 (da) Nedbrydelig hæmostatsammensætning
DK3071053T3 (da) Præbiotisk sammensætning
DK2968146T3 (da) Liposomsammensætning med kontrolleret lægemiddelfrigivelse
FR3001392B1 (fr) Composition dermatologique amelioree
DK2956010T4 (da) Fedtsammensætning
BR112014032712A2 (pt) composição
FR3015291B1 (fr) Composition antiprurigineuse
DK3089778T3 (da) Ballonkateter
BR112016010004A2 (pt) Composição de duas partes
DK2978414T3 (da) Sammensætning omfattende hydrocortison
FR3006896B1 (fr) Composition photoprotectrice
DK3057450T3 (da) Fødevaresammensætning
DK2800573T3 (da) Oftalmologisk sammensætning
DE112013006363A5 (de) Endoskop